Buffa, Francesca M <br/><br/>
A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancer.  [electronic resource] 

 -  European journal of nuclear medicine and molecular imaging  Aug 2003 
 - 1114-24 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1619-7070 
<br/><br/><label>Standard No.: </label>10.1007/s00259-003-1197-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Body Burden<br/>Bone Marrow--pathology<br/>Bone Neoplasms--diagnosis<br/>Computer Simulation<br/>Etidronic Acid--administration & dosage<br/>Humans<br/>Injections, Intravenous<br/>Male<br/>Models, Biological<br/>Organometallic Compounds<br/>Prognosis<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--diagnosis<br/>Radiometry--methods<br/>Radionuclide Imaging<br/>Radiopharmaceuticals--administration & dosage<br/>Radiotherapy Planning, Computer-Assisted--methods<br/>Relative Biological Effectiveness<br/>Rhenium--administration & dosage<br/>Statistics as Topic<br/>Treatment Outcome<br/>Whole-Body Counting--methods